Lisata Therapeutics sues Kuva Labs over breached merger agreement, seeks $2 million fee

Reuters2026/08/04 11:08

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Lisata Therapeutics filed suit in Delaware Chancery Court against Kuva Labs over an alleged breach of the March 6, 2026 merger agreement.
The complaint seeks damages for stockholders, including a USD 2 million termination fee under the merger agreement.
The litigation follows termination of the merger agreement with Kuva Labs and its Kuva Acquisition unit.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lisata Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608040700PRIMZONEFULLFEED9802924) on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Lisata Therapeutics sues Kuva Labs over breached merger agreement, seeks $2 million fee

You may also like

Crypto prices